Curis Inc Stock - CRIS Share Price Today, News and Discussion

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.

Sector:

Health Technology

Industry:

Biotechnology

Employees:

60

Current Price	$0.7608
Prev Close	$0.78
Open	$0.76
Dividend Yield	0.00%
50-Day Moving Average	$0.68
Beta	0.70
Avg. Volume	712,912.50
PE Ratio	N/A

52-Week High	$3.76
52-Week Low	$0.47
Market Capitalization	$75.19M
EPS	-$0.6401
Price to Book	1.35
Revenue Per Employee	$173,500.00
Enterprise Value/EBITDA	-0.40

No CRIS news at the moment.

CRIS Curis Inc

About

Feed

Fundamentals

News